The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Response Surface Model for Anesthetic Drug Interactions
Open accessAbstract
Click on the links below to access all the ArticlePlus for this article.Please note that ArticlePlus files may launch a viewer application outside of your web browser.DRUG interactions are the basis of anesthetic practice. For example, induction of anesthesia may consist of intravenous administration of a benzodiazepine before induction, a hypnotic to achieve loss of consciousness, and an opioid to blunt the response to noxious stimulation. Similarly, anesthesia often is maintained with a combination of a hypnotic (e.g. , propofol, isoflurane) and an analgesic (e.g. , fentanyl, nitrous oxide). Anesthetic drugs are often combined because they interact synergistically to create the anesthetized state.Pharmacodynamic drug interactions are typically described using mathematical models. The basic model is that of an isobole. Isoboles are iso-effect curves, curves that show dose combinations that result in equal effect. 1The combination of two doses (d1and d2) can be represented by a point on a graph, the axes of which are the dose axes of the individual drugs (fig. 1). The isobole connects isoeffective doses of the two drugs when administered alone, D1and D2. If the isobole is straight (fig. 1A), then the relation is additive. If the isobole bows toward the origin (fig. 1B), then smaller amounts of both drugs are needed to produce the drug effect when administered together, so the relation is supraadditive or synergistic. If the isobole bows away from the origin (fig. 1C), then greater amounts of both drugs are needed to produce the drug effect when administered together, so the relation is infraadditive. In table 1we propose a set of criteria that pharmacodynamic models of drug interactions should meet. In this article we propose an interaction model that meets these criteria, based on response-surface methodology. Response surfaces are a powerful statistical methodology for estimating and interpreting the response of a dependent variable to multiple inputs. 2Response-surface methodology is used for two principal purposes; to provide a description of the response pattern in the region of the observations studied and to assist in finding the region in which the optimal response occurs. Our model is a straightforward extension of the sigmoidal concentration–response relation for individual drugs. We test the proposed model using data from a study of the interaction of midazolam, propofol, and alfentanil with loss of consciousness. 3This article only considers pharmacodynamic interactions, the type of interaction most relevant to the practice of anesthesia. Pharmacokinetic interactions are entirely different and will not be considered. Appendix 1 (which can be found on the Anesthesiology Web site at www.anesthesiology.com) reviews several commonly used pharmacodynamic models of drug interactions and shows areas in which existing models fail to meet the criteria in table 1.The effects of individual drugs are often modeled by relating drug effect (E) to drug concentration (C) using a sigmoid model:where E0is the baseline effect when no drug is present, Emaxis the peak drug effect, C50is the concentration associated with 50% drug effect, and γ is a “sigmoidicity factor” that determines the steepness of the relation.This relation is shown graphically in figure 2. The concentration term often is defined as the concentration at the site of drug effect, but the model can be generalized to any measure of exposure (e.g. , dose, plasma concentration, or area under the curve). For models of probability, such as the probability of moving in response to surgical incision, E0is 0 and Emaxis the maximal probability (usually assumed to be 1). Dividing the numerator and denominator of equation 1by C50γ, we obtain an alternate form:In this model, concentration has been normalized to the concentration that results in 50% of maximal drug effect. This is a natural way to think about drug concentration—as a fraction of some measure of potency. For example, anesthesiologists are accustomed to thinking about volatile anesthetics in terms of minimum alveolar concentration (MAC), rather than in absolute concentration terms. This is precisely the concept of normalizing drug concentration to potency.The basic concept of our proposed interaction model is simple. Consider two drugs, each of which has a sigmoidal concentration–response relation. We will think of any given ratio (i.e. , B/(A + B), called θ herein) of the two drugs as behaving as a new drug. This new drug, which is actually a fixed ratio of the two drugs, has its own sigmoidal concentration–response relation, as shown in figure 3. This is the basic premise of our interaction model. The mathematics are simply an extension of the model for a single drug to a model that considers each ratio of two drugs as a drug in its own right. We will express the concentrations of drugs A and B as [A] and [B]. As suggested by equation 2, we must first normalize each drug to its potency, C50, and
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
The Influence of Age on Propofol Pharmacodynamics
Schnider, T. W., Minto, C. F., Shafer, S. L., Gambus, P. L., Andresen, C., Goodale, D. B., & Youngs, E. J. (1999) · Anesthesiology · doi:10.1097/00000542-199906000-00003 · Cited by 1,064
Self-citationNeter, J., Wasserman, W., & Kutner, M. (1990) · Cited by 635
HYPNOTIC AND ANAESTHETIC INTERACTIONS BETWEEN MIDAZOLAM, PROPOFOL AND ALFENTANIL
SHORT, T. G., PLUMMER, J. L., & CHUI, P. T. (1992) · British Journal of Anaesthesia · doi:10.1093/bja/69.2.162 · Cited by 162
Self-citationBührer, M., Maitre, P. O., Crevoisier, C., & Stanski, D. R. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.192 · Cited by 135
Norberg, L., & Wahlström, G. (1988) · PubMed · Cited by 15
Cited by
The Hill equation: a review of its capabilities in pharmacological modelling
Goutelle, S., Maurin, M., Rougier, F., Barbaut, X., Bourguignon, L., Ducher, M., & Maire, P. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00633.x · Cited by 867
Clinical pharmacokinetics and pharmacodynamics of propofol
Sahinovic, M. M., Struys, M. M. R. F., & Absalom, A. R. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0672-3 · Cited by 809
Bouillon, T. W., Bruhn, J., Radulescu, L., Andresen, C., Shafer, T. J., Cohane, C., & Shafer, S. L. (2004) · Anesthesiology · doi:10.1097/00000542-200406000-00006 · Cited by 375
Self-citationIs Synergy the Rule? A Review of Anesthetic Interactions Producing Hypnosis and Immobility
Hendrickx, J. F. A., Eger, E. I., Sonner, J. M., & Shafer, S. L. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31817b859e · Cited by 269
Self-citationDanhof, M., de Jongh, J., De Lange, E. C. M., Della Pasqua, O., Ploeger, B. A., & Voskuyl, R. A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105154 · Cited by 258
Metadata
- Authors
- Minto, C. F., Schnider, T. W., Short, T. G., Gregg, K. M., Gentilini, A., & Shafer, S. L.
- Venue
- Anesthesiology
- Published
- 2000-06-01
- Volume
- 92
- Issue
- 6
- Pages
- 1603-1616
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2091787052
- Cited by
- 353
- References
- 6
- FWCI
- 9.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Response Surface Model for Anesthetic Drug Interactions. https://app.cochat.ai/papers/10.1097/00000542-200006000-00017
- The paper
- Minto, C. F., Schnider, T. W., Short, T. G., Gregg, K. M., Gentilini, A., & Shafer, S. L. (2000). Response Surface Model for Anesthetic Drug Interactions. Anesthesiology. https://doi.org/10.1097/00000542-200006000-00017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.